Rett syndrome is an X-linked neurological condition affecting almost exclusively girls that is caused by mutations of the MECP2 gene. Recent studies have shown that transgenic delivery of MeCP2 function to Mecp2-deficient male mice can improve their Rett-like behavior. However, as the brain of a Rett girl contains a mosaic of MeCP2 expressing and non-expressing neurons, and the over-expression of MeCP2 in neurons can induce a severe progressive neurological phenotype, testing whether functional rescue can be achieved by gene reintroduction strategies in a female model of Rett syndrome is warranted. To address this, we generated transgenic mice expressing an epitope-tagged Mecp2 transgene in forebrain neurons. These mice over-express MeCP2 protein at about 1.6X normal levels in cortex, and develop impaired motor behavior by
Introduction
Rett syndrome is a pediatric neurological disorder first described in 1966 that affects primarily young girls (1) . Typical symptoms appear gradually over time, and include stereotypical hand wringing, loss of acquired speech, cognitive impairment, loss of locomotive ability, breathing irregularities, difficulty in eating and intractable seizures (2, 3, 4) . Physically, Rett girls tend to have significantly shorter life spans, are growth retarded, and of particular note, the brain of a Rett child is both undersized and under-weighted. In fact, the average size of a mature Rett brain is approximately the same as that of a 12-month infant (5, 6, 7) . Despite the reduced brain size, however, decreases in neuronal number have not been detected. Rather, a decrease in the degree of dendritic branching has been reported, particularly in cortical brain regions (8) . These observations have led to the hypothesis that Rett syndrome is a condition in which the brain either fails to mature, or is incapable of maintaining a mature phenotype (6, 9, 10) .
Loss-of-function mutations within the gene encoding methyl CpG binding protein type 2 (MECP2) are responsible for the majority of Rett syndrome cases (11) . Mutant mice have been developed that completely or partially lack MeCP2, and each of these lines develops a collection of behavioral impairments reminiscent of clinical Rett syndrome (12, 13, 14, 15) . These models have recently been utilized for proof-of-principle studies showing that global (16) and neuronally-targeted (17, 18, 19) re-introduction of functional MeCP2 improves at least some of the behavioral abnormalities of male Mecp2-deficient mice.
Furthermore, phenotypic improvement can also be achieved in symptomatic male and female MeCP2-deficient mice by reactivating endogenous Mecp2 expression (20) . Collectively, these studies show that the Rett-like phenotype of these mutant mice is not irremediable, and raises the possibility that gene reintroduction strategies may have clinical potential.
Due to the X-linked nature of MECP2 and random X chromosome inactivation, however, the brain of a Rett girl contains a mosaic of MECP2 wild-type and MECP2 mutant expressing neurons (3, 7, 21) . As moderate over-expression of MeCP2 is sufficient to induce neurological impairment (16, 17) , it remains unknown whether a similar targeted transgenic complementation strategy that was beneficial in Mecp2-null males, would also be beneficial in female subjects, where the reintroduction would elevate the expression of MeCP2 in the neurons expressing the wild-type allele. In this study, we address this issue by testing whether the behavioral deficits of female Mecp2 -/+ mice can be improved by the ectopic re-introduction of an epitope tagged Mecp2 transgene specifically in forebrain neurons.
Results

Transgenic mice over-expressing MeCP2 in forebrain neurons develop delayed behavioral impairments.
Mutant mice were generated in which a tetracycline response element (TRE)-containing promoter cassette was fused to a hemagglutinin (HA) tagged mouse Mecp2-e2 cDNA ( Figure 1 ).
Four lines of transgene-positive founder mice were identified by Southern blot and PCR. Each line was expanded by backcrossing with C57B/6 wild-type mice (see Methods). None of these single transgenic lines expressed the transgene at detectable levels in brain, indicating that the random insertion of the transgene did not promote its activation (not shown). Each transgenic line was viable, fertile, and their adult body weight did not differ from wild-type mice of the same litter (data not shown). Mice from each founder line were crossed with calcium calmodulin kinase IIα promoter driven reverse tetracycline transactivator (CamKII-rtTA) transgenic mice to generate the inducible transgenic mice. For simplicity and consistency with a recent report (19) , these double transgenic mice will be referred to as "inducible transgenics". In contrast to expectation, however, immunoblot analysis of cortical tissue from inducible transgenic line B mice revealed that the transgene was expressed basally, in the absence of tetracycline or analog Immunohistochemical assessments of the brain from adult inducible transgenic Line B mice revealed that the HA-MeCP2 transgene was expressed in cortex and striatum, while little or no transgene immunoreactivity was detected in thalamus, or brain stem (Figure 2 ). High-resolution fluorescence microscopy revealed that transgene immunoreactivity localized largely within the nucleus, where it displayed a predominantly punctate staining pattern that overlapped with major satellite DNA regions (Figure 2 ). Occasional neurons were identified in cortex and striatum in which the transgene displayed perinuclear or diffuse cytoplasmic staining, but these neurons constituted less than 10% of the total transgene-positive population. It is worth noting that in this inducible transgenic line, little or no transgene expression was detected within the hippocampus (Figure 2 ), despite strong transgene expression being previously observed in the hippocampus of other inducible transgenic mice generated with the same CamKII-rtTA transgenic mouse (22) .
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While the reason for this atypical expression profile is unclear, it may result from position effects relating to the site of transgene integration in the genome.
MeCP2 over-expression in forebrain neurons is sufficient to promote delayed behavioral impairments.
Previous studies have demonstrated that mice over-expressing MeCP2 at two-fold or greater levels throughout the brain develop severe behavioral impairments (16, 17) . To test whether the modest elevation in MeCP2 selectively in forebrain neurons would also induce phenotypic deficits, the behavior of the inducible transgenic mice was assessed using the open field behavioral apparatus (see Methods). These assessments were done first between 3 and 6 months of age, and then again on the same cohort of subjects between 9 and 12 months of age. No significant differences in total activity, rearing activity, time spent motionless, or average activity speed was observed between wild-type and the inducible transgenic mice at 3-6 months of age ( Figure 3 ). By 9-12 months of age, however, several significant impairments were detected in the inducible transgenic mice. Compared to age-matched female wild-types, female inducible transgenics at this age displayed 26% less total active time, 46% fewer total rearing events, and spent twice the amount of time immobile (Figure 3 ). Although less active overall, when these mice were active their average activity speed did not differ from wild-type mice. This suggests that the observed behavioral impairments do not arise from neuromuscular axis deficits, but rather from neuronal impairment. Thus, consistent with what has been observed previously for higher levels of MeCP2 over-expression (16, 17) , the modest over-expression of MeCP2 selectively in forebrain neuronal populations is sufficient to induce behavioral impairments in mice, but with a more delayed onset time and an overall diminished level of severity (16, 17) .
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To examine whether the over-expression of MeCP2 in forebrain neurons had any effect on motor co-ordination, we examined the balance performance of the inducible transgenics on the rotorod apparatus. No significant differences in the average latency time before falling off the rotating rod, or the rotational speed that was tolerated before falling, were detected between the inducible transgenic and wild-type mice ( Figure 3 ). In addition, the rotorod paradigm that we employed allowed task improvement rate to be assessed. Consistent with above, no significant differences in improvement rate were observed between wild-type or Line B inducible transgenic mice ( Figure 3) . (20) . Consistent with these previous observations, our cohort of 3-6 month old female Mecp2 -/+ mice did not display any significant differences from age-matched (20, 23) , and intriguingly, their impaired behavior was similar in magnitude to what was observed for our inducible transgenic mice ( Figure 3) . In contrast to the impaired performances observed for both the female Mecp2 -/+ mice ( Figure 4 ) and the inducible transgenics at 9-12 months of age (Figure 3 ), the behavior of our rescue mice in several open field parameters was significantly improved, and restored to wild-type levels ( Figure 4 ). For example, the total time spent mobile, the average rate of mobility, the total number of rearing events, and the number of complete cage explorations for the rescue group were equivalent to wild-type levels, and significantly improved above the values of the female
Mecp2
-/+ mice. These results therefore indicate that the ectopic re-introduction of MeCP2 into female Mecp2 -/+ mice can rescue at least some of their behavioral deficits without introducing the deficits caused by MeCP2 over-expression. Similarly, as our inducible transgenic mice also displayed deficits in these behaviors, these results indicate that a mosaic diminution of MeCP2 can also rescue the impaired behavior resulting from its over-expression.
The impaired balance and center-field rearing activity of female Mecp2 -/+ mice is not improved by forebrain expression of the HA-MeCP2 transgene.
In addition to the impairments in open field behavior presented above, female Mecp2 -/+ mice of 9-12 months age also demonstrated behavioral impairment on the rotorod task, and showed significantly diminished rearing activity in the center region of the open field apparatus ( Figure   5 ). In contrast to the restoration of behavioral performances presented above, however, neither the impaired rotorod balance performance, nor the deficit in center field rearing of the heterozygous Mecp2 -/+ mice were significantly improved in the rescue mice. In the open field test, 9-12 month old female Mecp2 -/+ mice displayed less than 3% the number of center field
rears in the open field apparatus compared to age-matched female wild-types. Both their fast and slow center rearing activity was similarly affected ( Figure 5 ). While there was a trend towards modest improvement in the average center field rearing activity of the rescue mice (18% of wildtype levels), this increase was not statistically different from the Mecp2 -/+ mice (p=0.084, Figure   5 ). A similar modest trend but overall lack of significant improvement compared to Mecp2 -/+ mice was observed for the fast and slow center rearing activity (p=0.068 and 0.089, respectively) of the rescue mice. On the rotorod apparatus, the lack of behavioral improvement in the rescue mice was clearly apparent. The performance of 9-12 month old female Mecp2 -/+ mice on the rotorod test was significantly impaired compared to wild-type for each trial after the first on day 1 ( Figure 5 ). The performance of the rescue mice on the rotorod was not significantly different on any trial from female Mecp2 -/+ mice, and remained well below the performance levels of the wild-types. Thus, although functional improvement was achieved in some behavioral tasks by targeted reintroduction of MeCP2, these data also show that the forebrain expression of the HAMecp2 transgene was not able to correct the balance deficiency or the diminished center field rearing activity of older female Mecp2 -/+ mice.
Discussion
In this study, we tested whether specific aspects of the Rett-like behavior of heterozygous
Mecp2
-/+ female mice could be improved by forebrain targeted MeCP2 transgene delivery. Our strategy was to employ an inducible transgene system that in principle should allow the transgene to be induced at specific times by pharmacological activation of the transactivator protein. Such a system would allow one to activate the transgene both prior to and after the onset of Rett-like symptoms in the inducible transgenic mice. While the conditional inducibility of the tetracycline responsive system has been demonstrated previously (22) , our mice expressed the transgene at a basal level, and this expression was sufficient to induce behavioral impairments at later stages of development. This result is not necessarily unexpected, as the ability of the rtTA factor to bind weakly to TREs in the absence of tetracycline has been shown previously (24, 25) . Although this basal expression precluded an induction study, the impaired behavioral performance of our mice comports well with previous studies demonstrating global MeCP2 over-expression induces behavioral deficits (16, 17) . Collectively, these results highlight that even the modest over-expression of MeCP2 in specific neuronal populations is sufficient to promote delayed behavioral impairments in mice.
Our study also complements recent rescue reports in male Mecp2-null mice by Giacometti et al (18) and Alvarez-Saavedra et al (19) MeCP2 transgene at higher levels. In addition, it is also worth noting that the improved behavior of our rescue group indicates that at least some of some of the behavioral deficits caused by the over-expression of MeCP2 (Figure 3) can be improved by a mosaic diminution of MeCP2 expression.
Our observation that some of the behavioral deficiencies of female Mecp2 -/+ mice can be corrected by transgenic reintroduction adds to the growing evidence that Rett syndrome is not an irremediable condition. Recently, however, Alvarez-Saavedra et al (19) reported that targeted restoration of MeCP2 into forebrain neurons using a similar CamKII promoter driven 13
transactivating system to what we employed failed to rescue the primary phenotypic abnormalities of Mecp2 -/y and Mecp2 308/y male mice. While the results of our study may appear to contrast with theirs, they focused on Mecp2-deficient male mice, which have a more severe phenotype than Mecp2 -/+ female mice, and employed a more robust transactivator system (tTA verses rtTA). Despite these differences, and the lack of significant improvement of lifespan, tremor onset, or breathing irregularities observed in their inducible male rescue mice, it should be noted that two common outcomes were seen in our respective studies: both found that targeted reintroduction improved the mobility times of Mecp2-deficient mice in the open field, and neither found an improvement in the rescue mice on the rotorod test (19) . A similar restoration of mobility was observed during the symptomatic phase of Mecp2 -/y mice in the rescue study of Giacometti et al (18) , although this effect dissipated as the male mice acquired a more severe phenotype.
While the reason for the lack of pronounced behavioral improvement in the rotorod and center field exploration in our rescue mice remains unclear, there are several possible explanations. In addition to involving motor cortex and striatum, which are targeted by the CamKII promoter and express the MeCP2 transgene in our rescue mice, the cerebellum and spinal cord also contribute to rotorod performance (28) . Few neurons within either of these structures expressed the MeCP2 transgene in our inducible transgenic mice (not shown). Thus, if the deficiency in rotorod performance arises, at least in part, from impaired function in neurons of the cerebellum and spinal cord, the lack of significant improvement in our rescue animals would not be surprising.
Similarly, anxiety levels negatively influence center field exploration and rearing, and a recent study by McGill et al (29) demonstrated elevated levels of corticotrophin releasing hormone expression in the paraventricular nucleus of the hypothalamus in Mecp2-deficient mice. As transgene expression was not detected in this brain region in our inducible transgenics, this imbalance in stress axis regulation would likely be retained in our rescue mice. Thus, while it is possible that the inability to rescue these behavioral deficits relate to improper expression levels of the transgene in specific neurons, or simply that these behaviors are not amenable to being rescued, an alternative explanation is that the transgene was not expressed in the correct population of neurons to address these deficits. While additional experiments will be required to delineate the reason, the lack of pronounced improvement in these tasks by our rescue mice strengthens our conclusion that the rescue observed in the open field tasks arises directly from the reintroduction of MeCP2 into the targeted forebrain neurons. Taken together, these results support the possibility that targeted gene reintroduction strategies -if maintained within a tolerable window of expression -could be used to improve some of the behavioral deficiencies caused by the mosaic loss of MeCP2. Tissue Isolation. Tissue preparation for immunoblots was done as described previously (33) . In brief, mice were sacrificed by decapitation, and their brain removed from the skull and chilled on an ice-cold dissection disc. The cortex was isolated, frozen on dry ice, and homogenized in immunoblot lysis buffer (150 mM NaCl, 1mM EDTA, 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, 1% (v/v) Nonidet P-40), supplemented with the protease inhibitors aprotinin (100 μg/ml), leupeptin (100 μg/ml), and phenylmethylsulfonyl fluoride (2 mM). In (E), the average rate at which the subject performs an activity is shown in the left panels, while the average number of complete front to rear exploration trips taken by a subject during the observation period is presented in the right panels. Asterisks denote statistically significant differences between wild-type and inducible transgenics at the specific task and age (one way ANOVA, p<0.05). In (F), the time subjects balanced themselves on an accelerating rotating rod is presented in seconds. The test was performed three times a day for four successive days. The time spent on the rod was recorded when the subject fell. Mice that held onto the rod and circled during a trial were excluded from analysis. No significant differences were observed in the rotorod performance between the wild-type and inducible transgenic mice, and no differences were observed in the rate at which the different groups improved their performance on the task (one way ANOVA, p<0.05). showed significantly fewer total rears in the center field, and both their fast and slow rearing activity in the center field were diminished from wild-type levels. 
Materials and Methods
Generation
